Natera, Inc.: Form 10-Q for the period ended Mar 31, 2025
Filed with the SEC on May 9, 2025 and accepted by EDGAR at May 8, 2025, 19:35 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2025-03-31. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2025-01-01 to 2025-03-31 | $501.8m | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Research and development | 3 months2025-01-01 to 2025-03-31 | $129.1m | us-gaap:ResearchAndDevelopmentExpense |
| Selling, general and administrative | 3 months2025-01-01 to 2025-03-31 | $266.9m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 3 months2025-01-01 to 2025-03-31 | −$79.2m | us-gaap:OperatingIncomeLoss |
| Interest expense | 3 months2025-01-01 to 2025-03-31 | $1.0m | us-gaap:InterestExpense |
| Income tax | 3 months2025-01-01 to 2025-03-31 | $173.0k | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2025-01-01 to 2025-03-31 | −$66.9m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2025-01-01 to 2025-03-31 | −$0.50 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2025-01-01 to 2025-03-31 | −$0.50 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months2025-01-01 to 2025-03-31 | 134,750,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 3 months2025-01-01 to 2025-03-31 | $44.5m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 3 months2025-01-01 to 2025-03-31 | $21.8m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Current assets | At period end2025-03-31 | $1.42bn | us-gaap:AssetsCurrent |
| Total assets | At period end2025-03-31 | $1.73bn | us-gaap:Assets |
| Current liabilities | At period end2025-03-31 | $365.7m | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2025-03-31 | $492.7m | us-gaap:Liabilities |
| Short-term borrowings | At period end2025-03-31 | $80.3m | us-gaap:ShortTermBorrowings |
| Shareholders' equity | At period end2025-03-31 | $1.24bn | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0001558370-25-007036. Last ingested by Listed: Nov 6, 2026, 12:42 ET. Listed shows no prices and gives no investment advice.